Breaking News

Civica to Build an Essential Medicines Manufacturing Facility in Virginia

Will produce sterile injectable meds used in hospitals for COVID-19 patient care.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Civica Rx has unveiled plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, VA, potentially creating more than 180 jobs. The new plant represents a $124.5 million investment.   Building its own state-of-the-art manufacturing operation in the U.S. has been a part of Civica’s supply strategy since it was founded by leading health systems and philanthropies in late 2018 to address drug shortages and ensure a resilient supply of quality medicines at affordabl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters